Jun. 20 at 9:14 PM
This coming week might be a good time for biotech stocks!!
The coming week is shaping up to be massive for the biotech sector due to a flurry of major clinical data readouts, key FDA decisions, and the kickoff of the industry's premier global partnering event.
The BIO International Convention: Running June 22–25 in San Diego, this is the largest biotechnology event globally. It regularly drives high levels of M&A activity, licensing deals, and early-stage capital inflows. You can check the conference program or track participating companies on the
High M&A and Buyout Pressures: Large-cap pharmaceutical companies are under significant pressure to replenish their pipelines ahead of major patent expirations. With significant cash on hand, they are actively acquiring clinical-stage assets. High-profile recent acquisitions, like Biogen's buyout of RayThera, highlight this trend.
$CGEN
$OTLK
$NRSN
$TRAW
$COCH